Login to Your Account



Other News To Note


Thursday, October 25, 2012
• Cytheris SA, of Paris, said the European Commission granted orphan drug status to CYT017 for progressive multifocal leukoencephalopathy (PML).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription